Exosome Therapeutics Are Paving a Path to Clinical Readiness
Exosomes show potential to treat myriad conditions, including cancer and inflammation, but experts are divided on whether the therapies are ready for the limelight.
Source: biospace.com
Extracellular Vesicles News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Extracellular Vesicles. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Extracellular Vesicles Today - Breaking & Trending Today
TOPPAN Establishes Method of Quantifying Simple Qualitative Test Results through Digital Image Color Management Techniques
TOPPAN Establishes Method of Quantifying Simple Qualitative Test Results through Digital Image Color Management Techniques
Source: whattheythink.com
NurExone's Intellectual Property Portfolio Expands
Innovations and know-how in exosome production suited for many clinical applicationsTORONTO and HAIFA, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, proudly underscores its expanding Intellectual Property (IP) portfolio, which will serve as the foundation for its strategic goal of licensing the innovative ExoTherapy platform to interested biotech companies. NurExone’s Intellectual
Source: yahoo.com
Husker research duo selected as Phase 1 winners in the NIH's Targeted Genome Editor Delivery Challenge
A Husker research duo was named a first-round winner in a National Institutes of Health competition aimed at generating solutions for delivering genome-editing technology to the cells of people with rare and common diseases.
Source: news-medical.net
NurExone Launches Licensing Efforts for ExoTherapy
NurExone Biologic launches licensing efforts for its ExoTherapy platform for creating nanodrugs by loading therapeutic molecular cargo into exosomes. ...
Source: globenewswire.com